Correlation Between CSL and Legend Biotech
Can any of the company-specific risk be diversified away by investing in both CSL and Legend Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CSL and Legend Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CSL and Legend Biotech Corp, you can compare the effects of market volatilities on CSL and Legend Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CSL with a short position of Legend Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of CSL and Legend Biotech.
Diversification Opportunities for CSL and Legend Biotech
0.83 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between CSL and Legend is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding CSL and Legend Biotech Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Legend Biotech Corp and CSL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CSL are associated (or correlated) with Legend Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Legend Biotech Corp has no effect on the direction of CSL i.e., CSL and Legend Biotech go up and down completely randomly.
Pair Corralation between CSL and Legend Biotech
Assuming the 90 days horizon CSL is expected to under-perform the Legend Biotech. But the pink sheet apears to be less risky and, when comparing its historical volatility, CSL is 2.18 times less risky than Legend Biotech. The pink sheet trades about -0.21 of its potential returns per unit of risk. The Legend Biotech Corp is currently generating about -0.09 of returns per unit of risk over similar time horizon. If you would invest 4,530 in Legend Biotech Corp on August 29, 2024 and sell it today you would lose (272.00) from holding Legend Biotech Corp or give up 6.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
CSL vs. Legend Biotech Corp
Performance |
| Timeline |
| CSL |
| Legend Biotech Corp |
CSL and Legend Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with CSL and Legend Biotech
The main advantage of trading using opposite CSL and Legend Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CSL position performs unexpectedly, Legend Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Legend Biotech will offset losses from the drop in Legend Biotech's long position.| CSL vs. Advanced Proteome Therapeutics | CSL vs. ChitogenX | CSL vs. Northwest Biotherapeutics | CSL vs. Geron |
| Legend Biotech vs. Vaxcyte | Legend Biotech vs. Apellis Pharmaceuticals | Legend Biotech vs. Travere Therapeutics | Legend Biotech vs. Akero Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |